Literature DB >> 22866100

Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature.

Machiko Hotta1, Mitsuaki Ishida, Fumiyoshi Kojima, Yasuhiro Iwai, Hidetoshi Okabe.   

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is an uncommon cancer-related complication characterized by intimal proliferation in pulmonary small arteries and arterioles with or without tumor emboli. In the majority of cases, the causative lesion is gastric poorly differentiated adenocarcinoma. In the present study, an autopsy case of PTTM caused by lung adenocarcinoma is reported and the pathogenesis of this complication is discussed. Multiple nodular lesions in the bilateral lungs were found in a 62-year-old Japanese man. Transbronchial biopsy revealed non-small cell carcinoma. Chemotherapy was performed; however, the patient succumbed to sudden dyspnea. Autopsy revealed poorly differentiated adenocarcinoma with multiple intrapulmonary metastases and intimal proliferation of pulmonary small arteries and arterioles with or without tumor emboli, which were characteristic of PTTM. Tumor cells were immunohistochemically positive for vascular endothelial growth factor (VEGF) and osteopontin (OPN), which are endothelial proliferative factors. This case indicates the possible involvement of VEGF and OPN in the pathogenesis of PTTM caused by lung adenocarcinoma.

Entities:  

Year:  2011        PMID: 22866100      PMCID: PMC3410503          DOI: 10.3892/ol.2011.270

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  6 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Pulmonary tumor thrombotic microangiopathy.

Authors:  Shinsuke Miyano; Shinyu Izumi; Yuichiro Takeda; Makoto Tokuhara; Makoto Mochizuki; Osamu Matsubara; Hiromi Kuwata; Nobuyuki Kobayashi; Koichiro Kudo
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

3.  Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension.

Authors:  A von Herbay; A Illes; R Waldherr; H F Otto
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

4.  Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.

Authors:  Fumiyuki Takahashi; Toshio Kumasaka; Tetsutaro Nagaoka; Midori Wakiya; Hiroaki Fujii; Kazue Shimizu; Koji Uchida; Yoshiteru Morio; Kuniaki Seyama; Okio Hino; Kazuhisa Takahashi; Yoshinosuke Fukuchi
Journal:  Pathol Int       Date:  2009-10       Impact factor: 2.534

5.  Pulmonary tumor thrombotic microangiopathy resulting from metastatic signet ring cell carcinoma of the stomach.

Authors:  Naomi Sakashita; Chiharu Yokose; Kazuhiko Fujii; Mitsuhiro Matsumoto; Koji Ohnishi; Motohiro Takeya
Journal:  Pathol Int       Date:  2007-06       Impact factor: 2.534

6.  [A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy].

Authors:  Hironori Uruga; Nasa Morokawa; Takahiro Enomoto; Hisashi Takaya; Atsushi Miyamoto; Kazuma Kishi; Atsuko Kurosaki; Takeshi Fujii; Kunihiko Yoshimura
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2008-11
  6 in total
  7 in total

1.  Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma.

Authors:  Funda Demirag; Ebru Cakir; Ulku Yazici; Irfan Tastepe
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 2.  The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature.

Authors:  Andrew L K Ho; Patryk Szulakowski; Patryk Szulakowsi; Waria H S Mohamid
Journal:  BMC Cancer       Date:  2015-06-03       Impact factor: 4.430

3.  An elderly lady with Fever of unknown etiology and severe pulmonary hypertension: intravascular lymphoma-an elusive diagnosis.

Authors:  Nupur Sinha; Luis Lantigua; Masooma Niazi; Gilda Diaz-Fuentes
Journal:  Case Rep Med       Date:  2013-12-19

Review 4.  Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature.

Authors:  Eukene Gainza; Sara Fernández; Daniel Martínez; Pedro Castro; Xavier Bosch; José Ramírez; Arturo Pereira; María T Cibeira; Jordi Esteve; Josep M Nicolás
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

5.  Possibility of venoarterial extracorporeal membranous oxygenator being a bridging therapy for hemodynamic deterioration of pulmonary tumor thrombotic microangiopathy prior to initiating chemotherapy: A case report.

Authors:  Yoshiaki Iwashita; Takuya Hiramoto; Kei Suzuki; Ryotaro Hashizume; Kazuo Maruyama; Hiroshi Imai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies.

Authors:  Carme Font; Marta García de Herreros; Nikolaos Tsoukalas; Norman Brito-Dellan; Francis Espósito; Carmen Escalante; Thein Hlaing Oo
Journal:  Support Care Cancer       Date:  2022-05-12       Impact factor: 3.359

7.  A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies.

Authors:  Atsushi Kitamura; Naoki Nishimura; Torahiko Jinta; Rika Suda; Yasuhiko Yamano; Genta Ishikawa; Yutaka Tomishima; Tsuyoshi Hamaoka; Koyu Suzuki; Naohiko Chohnabayashi
Journal:  Case Rep Pulmonol       Date:  2013-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.